By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The component of the ultrasound system that contacts the patient’s body is the ultrasonic probe, sometimes referred to as a transducer. It houses the crystals responsible for sending and receiving acoustic pulses.
A transducer is a device, like a lightbulb or a television antenna, that converts energy from one form to another. Similar to this, the probe changes sound into electrical and vice versa before sending the information to the ultrasonic device for processing and display.
Copper alloy wire strands are stronger and more flexible than human hair, and they are thinner than a human hair. The products are put through rigorous tests, including continuous bending, pulling, and twisting more than 300,000 times under in-house testing conditions.
A variety of probe cables, including low capacitance types up to 46 AWG and high capacitance types up to 48 AWG, are available. They are not only good, but also made with thinner formed insulation with a low dielectric constant and high conductivity copper alloy conductors to maintain outstanding transmission performance with lesser loss.
Sound waves from an ultrasonic transducer, or probe, are sent into the target tissue in distinct bundles or pulses. A fraction of the waves are reflected back to the transducer when they hit tissue. The size and density of the tissue being studied determine the percentage of returning waves.
The amount of time needed for pulse emission and return establishes the depth of tissue. Thus, a B-mode, or grayscale, image may be produced by integrating the quantity of returning pulses and the time needed for return. Higher ultrasound probe frequencies result in a shorter time for wave reflection.
Higher frequency transducer probes photograph superficial tissues more effectively than lower frequency probes, but they lose depth imaging due to attenuation of the returning emitted pulses.
The Global ultrasound equipment probe cable market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The U.S. Food and Drug Administration (FDA) has granted Interson permission to market their SiMPLi Series ultrasound array probes for medical uses, the company stated today.
Medical practitioners can now view real-time ultrasound pictures on Windows tablets and laptops at quality and detail that were previously only possible on high-end ultrasound devices thanks to Interson’s new linear and convex array probes.
The new SiMPLi Series probes are portable, lightweight, and simple to transport to any patient location. The SiMPLi Series probes are so simple to use that they are now useful to all medical professionals.
To view real-time, high-resolution ultrasound images on a Windows computer, only connect the USB probe cord to the computer.